LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
10,873,590
Share change
+794,167
Total reported value
$266,508,413
Put/Call ratio
44%
Price per share
$24.51
Number of holders
52
Value change
+$20,866,245
Number of buys
42
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2015

As of 30 Jun 2015, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,873,590 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, venBio Select Advisor LLC, Visium Asset Management, LP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Fund Advisors, and RTW INVESTMENTS, LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.